메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
이화여자대학교 국제지역연구소 Asian International Studies Review Asian International Studies Review 제8권 제1호
발행연도
2007.1
수록면
31 - 46 (16page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Worldwide property right of pharmaceutical medicine has been protected by 1995 WTO/TRIPs Agreement. However, disparities in access to treatment raise worrisome issues of equity. Since 1996, in the developed world, HIV/AIDS has become akin to other treatable chronic illnesses. However, in the developing and least-developed world, it remains a deadly plague. Differential investment in HIV/AIDS prevention and treatment program mirrors these disparities. While there is no provision that specifically refers to “right to pharmaceuticals,” the right to health is firmly grounded in the implications of several international human rights instruments. The public health issue relating to the pharmaceutical patent system was discussed in Doha round. Given the pressure by Third World nations and AIDS activists, in November 2001, the WTO Ministerial Conference issued a Declaration clarifying the sovereign power of Third World to use the flexibility already built into the TRIPs Agreement. Upon the request to find an expeditious solution for effective use of compulsory licensing under the TRIPs Agreement, on August 30, 2003, parties have reached an agreement. After 2003 decision, on December 6, 2005 WTO members agreed on an amendment to TRIPs to make the temporary waiver permanent. This General Council decision is the first amendment of the WTO Agreement.

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0